Keywords: b-ms, up, strong, sales, glucophage, bristol-myers, squibb
B-MS up on strong sales of Glucophage
Article | 24 July 2000
Bristol-Myers Squibb has reported a net income rise of 15% to $1.09billion for second-quarter 2000 on turnover of $5.28 billion, an increase of 7%. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
